Moreover, previous work has shown that inhibition of NF-κB signaling alleviates inflammation and restores Treg/Th17 balance in various immune-mediated disease models, such as sepsis-induced lung injury and asthma (47, 48). Here, NFKB1 is linked to Sepsis.